Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

Michael J. Doane(Alkermes (United States)), Jonathan M. Meyer(University of California San Diego)
BMC Psychiatry
February 14, 2022
Cited by 30


Related Papers